ICATIBANT TEVA

Страна: Ізраїль

мова: англійська

Джерело: Ministry of Health

Активний інгредієнт:

ICATIBANT AS ACETATE

Доступна з:

TEVA ISRAEL LTD

Код атс:

B06AC02

Фармацевтична форма:

SOLUTION FOR INJECTION

Склад:

ICATIBANT AS ACETATE 30 MG / 3 ML

Адміністрація маршрут:

S.C

Тип рецепту:

Required

Виробник:

TEVA ISRAEL LTD, ISRAEL

Терапевтична области:

ICATIBANT

Терапевтичні свідчення:

Icatibant Teva is indicated for symptomatic treatment of acute attacks of hereditary angioedima (HAE) in adults, adolescents and children aged 2 years and older, with C1-esterase-inhibitor deficiency.

Дата Авторизація:

2023-10-31

інформаційний буклет

PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor’s prescription only
Icatibant Teva
Solution for subcutaneous injection
Composition
Each syringe contains: Icatibant (as acetate) 30 mg / 3 ml
For information regarding inactive ingredients, see section 2
“Important information
about some ingredients of the medicine” and section 6 “Additional
information”.
Read the entire leaflet carefully before using the medicine. This
leaflet contains
concise information about the medicine. If you have additional
questions, refer to the
doctor or the pharmacist.
This medicine has been prescribed for treatment of your illness. Do
not pass it on to
others. It may harm them even if it seems to you that their medical
condition is similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
Icatibant Teva is used for symptomatic treatment of acute attacks of
hereditary
angioedema (HAE) in adults, adolescents and children two years of age
and older.
In situations of HAE, bradykinin levels in the blood rise, which
causes such effects as
swelling, pain, nausea and diarrhea.
Icatibant Teva blocks bradykinin activity and thus stops further
development of these
effects.
Therapeutic class: Other hematological agents, medicines for treatment
of hereditary
angioedema.
2. BEFORE USING THE MEDICINE:
Do not use this medicine if:
•
You are sensitive (allergic) to the active ingredient (icatibant) or
to any of the
additional ingredients the medicine contains (listed in section 6).
Special warnings regarding the use of the medicine:
Before treatment with Icatibant Teva, inform the doctor if:
•
You have angina (decreased blood flow to the cardiac muscle).
•
You had a stroke recently.
Some of the side effects associated with treatment with Icatibant Teva
are similar to
your illness’ symptoms. Inform the doctor immediately if you observe
worsening of the
attack’s symptoms after using Icatibant Teva.
In addition:
•
You or your caregiver should be trained in subcutan